A 28-year-old man from Mumbai presents to the emergency department with acute onset fever (39.8°C), severe headache, neck stiffness, and petechial rash on his trunk and extremities. CSF analysis shows: WBC 450/μL (90% neutrophils), protein 180 mg/dL, glucose 25 mg/dL. Gram stain reveals gram-negative diplococci. Blood culture is pending. The patient is immediately started on ceftriaxone. Which antibody class is most critical for opsonization and complement-mediated killing of Neisseria meningitidis in this patient?

Explanation

## Antibody-Mediated Defense Against Neisseria meningitidis **Key Point:** IgG is the most critical antibody class for opsonization and complement-mediated killing of encapsulated bacteria like *Neisseria meningitidis*, serving as the principal effector antibody in both primary and secondary immune responses against invasive meningococcal disease. ### Antibody Classes in Meningococcal Immunity | Antibody Class | Structural Feature | Role in N. meningitidis Defense | Timing | |---|---|---|---| | **IgG** | Monomer; 2 binding sites; most abundant serum Ig; activates classical complement pathway | **Primary opsonin; activates complement; mediates ADCC; crosses placenta** | **Dominant in secondary response; also present in primary response** | | **IgM** | Pentamer; 10 binding sites; potent early complement activator | First antibody produced; important in early primary response; poor opsonin due to large size | Early primary response only | | **IgA** | Dimer; mucosal immunity; poor complement activation | Prevents nasopharyngeal colonization; not effective against invasive disease | Mucosal surfaces | | **IgD** | Monomer; B cell receptor; minimal effector function | No direct role in bacterial killing | B cell surface | ### Why IgG is the Most Critical Antibody for Meningococcal Defense **1. Opsonization** - IgG is the **dominant opsonin** in serum. Fc receptors on neutrophils and macrophages (FcγRI, FcγRII, FcγRIII) bind IgG-coated bacteria with high affinity, enabling efficient phagocytosis. - IgM, despite its pentameric structure, is too large (900 kDa) to efficiently opsonize bacteria for phagocytosis; its primary role is complement activation in the very early primary response. **2. Complement-Mediated Bactericidal Killing** - IgG activates the classical complement pathway, leading to C3b deposition (opsonization) and MAC (C5b-9) formation (direct lysis). - Epidemiological studies (Goldschneider et al., 1969) demonstrated that **serum bactericidal activity against *N. meningitidis* correlates with IgG antibody titers**, not IgM titers, in the population. - IgG subclasses IgG1 and IgG3 are particularly effective at activating complement against meningococcal capsular polysaccharides. **3. Vaccine-Induced Protection** - All licensed meningococcal vaccines (conjugate vaccines: Menactra, Menveo; polysaccharide vaccines: Menomune) are designed to elicit **IgG responses** against capsular polysaccharides. - The conjugation of polysaccharide to protein carrier converts a T-independent IgM response into a T-dependent **IgG response** with immunological memory — confirming that IgG, not IgM, is the protective antibody class. **4. Abundance and Persistence** - IgG is the most abundant immunoglobulin in serum (~75% of total serum Ig), providing sustained protection. - IgM titers wane rapidly; IgG provides durable immunity. **High-Yield:** Patients with **complement deficiencies (C5-C9, properdin, factor H)** are at risk for recurrent meningococcal infections despite normal IgG levels, underscoring that IgG-mediated complement activation is the key bactericidal mechanism. (Harrison's Principles of Internal Medicine, 21st ed.) **Clinical Pearl:** The classic Goldschneider studies showed that susceptibility to meningococcal disease inversely correlates with serum **IgG** bactericidal antibody titers. Infants (6–24 months) are most susceptible because maternal IgG has waned and they have not yet developed their own IgG responses. **Why IgM is NOT the best answer:** While IgM is the first antibody produced in a primary immune response and can activate complement, it is a poor opsonin, is not the dominant protective antibody in meningococcal disease, and vaccine strategies specifically aim to generate IgG — not IgM — for protection. **Mnemonic:** **"IgG = Guardian against encapsulated bacteria"** — IgG is the principal opsonin and complement activator against encapsulated organisms including *N. meningitidis*, *S. pneumoniae*, and *H. influenzae*.